Table 3.
Median | Mean (SD) | |
---|---|---|
Viroxyn and Abreva users | ||
Control | 11.0 | 11.5 (3.8)* |
Abreva | 7.0 | 7.6 (2.2)† |
Viroxyn | 3.0 | 4.0 (2.0)‡ |
N = 180 | ||
Viroxyn only users | ||
Control (untreated cold sore) | 10.0 | 11.1 (3.3)* |
Viroxyn | 3.0 | 4.0 (2.5)† |
N = 58 |
Definition: loss of hard scab and return to intact skin.
Control versus Abreva (t-test; p < 0.001).
Control versus Viroxyn (t-test; p < 0.001).
Viroxyn versus Abreva (t-test; p < 0.001).